Large-Cap Stocks Mostly Lower on Monday, Tech Stocks Gain

E-mini Dow Jones Industrial Average

Boeing and other industrial companies fell Monday, giving back some of the ground they won late last week.

It had also risen against the euro (+0.2pc), but was steady against the British pound and Japanese yen. Economists had expected a gain of 200,000 jobs. The Nasdaq Composite climbed 0.2% after closing at a record on Friday.

Futures for the Dow Jones Industrial Average gained 96 points to 25,456.00, while the Standard & Poor's 500 index futures rose 9.45 points to 2,798.00.

In small-caps, the Russell 2000 closed at 1,601.06 for a gain of 3.91 points or 0.24%.

Stocks ended up split on Wall Street as gains for technology companies were offset by losses elsewhere. Wall Street anxious that that might be the start of faster inflation.

Investor sentiment remained upbeat at the start of the week after Friday's employment report showed stronger-than-expected United States job growth in February.

ALL EYES ON TECH: Optical communications company Oclaro surged after it agreed to be bought by optical networking company Lumentum Holdings.

Shares of Micron Technology (MU.O) rose 8.8 percent to $59.37 after analysts at Nomura raised their target for the stock to $100. Lumentum's shares rose 3.8 per cent.

Late Friday the Wall Street Journal reported that Intel might try to buy rival Broadcom. It could also attempt a smaller deal.

Shares of Broadcom Ltd. rose 3.6% after the Singapore-based semiconductor company said it expects to complete its relocation to the United States by 3 April.

Advancing issues outnumbered decliners on the two major exchanges, by a 1.17-to-1 ratio on the NYSE and a 1.40-to-1 ratio on the Nasdaq. Boeing gave up 2.9 percent and heavy equipment maker Caterpillar lost 2.4 percent. Blankfein is reportedly set to step down later this year.


Goldman's stock gained $1.83 to $272.60.

Broadcom gained 3.6 percent while shares in Qualcomm were flat. Liveris will be succeeded by co-director Jeff Fettig.

DowDuPont ultimately plans to break up into three companies.

Johnson Controls was up 1.6 percent after saying it would consider selling a business that makes batteries for vehicles.

General Electric rose 2.2 per cent and was the biggest boost to the Dow. Brent crude, used to price global oils, added 6 cents to $65.55 per barrel in London.

BONDS: Bond prices edged higher.

Bond prices rose. The yield on the 10-year Treasury note fell to 2.88 percent.

CURRENCY: The dollar weakened to 106.58 yen from Friday's 106.81 yen.

In early trading, Germany's DAX rose 0.8 percent to 12,446.46 and France's CAC 40 added 0.4 percent to 5,297.83. Japan's benchmark index Nikkei 225 slipped 0.22%.

Shanghai China Composite Index was up 0.58%.

Related:

Comments

Latest news

Private Member's bill moved by Sanjay Singh to end sealing drive
After the meeting, Maken said it was a fruitful discussion on the issue. This is unedited, unformatted feed from the Press Trust of India wire.

Teachers Advisors LLC Boosts Stake in Citizens Financial Group Inc (CFG)
Mutual Of America Mgmt Ltd Limited Liability Company holds 0.04% of its portfolio in Citizens Financial Group, Inc . The firm owned 24,993 shares of the bank's stock after purchasing an additional 1,532 shares during the quarter.

Former Bills WR Sammy Watkins expected to sign with Chiefs
Watkins' deal is expected to be worth $16 million per year over three years, according to Ian Rapoport of NFL Network. And he's a fantastic fit for the Chiefs, who now have a bunch of field stretchers on their versatile offense.

Federer through, Djokovic out at Indian Wells
Meanwhile, World No. 1 Roger Federer qualified for the Round of 32 with a 6-3, 7-6 victory over Argentina's Federico Delbonis. She defeated Bertens 7-6 (7/5), 7-5. "To me, it's not that surprising", the defending champion said in California.

KAMES CAPITAL plc Lowers Position in Pfizer Inc. (PFE)
Pfizer had 75 analyst reports since July 29, 2015 according to SRatingsIntel. ( NYSE:KS ), 2 have Buy rating, 2 Sell and 13 Hold. This buyback authorization authorizes the biopharmaceutical company to buy shares of its stock through open market purchases.

Other news